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Abstract The Wnt/beta-catenin/TCF4 pathway plays
critical roles in the maintenance of small intestinal epithe-
lium; however, downstream targets of the beta-catenin/
TCF4 complex are not extensively characterized. We
identified miR-30e as an immediate target activated by the
beta-catenin/TCF4 complex. miR-30e was detected in the
peri-nuclear region of the intestinal crypt IEC-6 cells.
Bioinformatics analysis revealed clustered beta-catenin/
TCF4 binding sites within the miR-30e promoter region.
This promoter region was cloned into pGL3-control lucif-
erase reporter vector, with the enhancer region removed.
Transfection of pCMV-SPORT6-beta-catenin expression
vector dose-dependently increased luciferase activity, and
co-transfection of pCMV-SPORT6-TCF4 expression vector
further enhanced the promoter activity. Dexamethasone-
induced IEC-6 cells differentiation caused a 2.5-fold
increase in miR-30e expression, and upon beta-catenin
siRNA transfection, miR-30e increased 1.3-fold. Electro-
phoretic mobility shift assay and chromatin immuno-
precipitation assay confirmed the binding between
beta-catenin/TCF4 complexes from IEC-6 nuclear extracts
and the putative sequences in the miR-30e promoter. These
results demonstrate that beta-catenin/TCF4 transactivates
miR-30e during intestinal cell differentiation.
Keywords MiR-30e  IEC-6 cells  Beta-catenin 
TCF4  Intestine  Differentiation
Introduction
The small intestine has two functionally distinct compart-
ments, villi and crypts of Lieberku¨hn (crypts). Villi are
finger-like protrusions extending to the intestinal lumen, and
contain three types of terminally differentiated cells: (1)
enterocytes are the only absorptive cells, whose function is to
absorb nutrients from food sources, and comprise the
majority of the villi; (2) enteroendocrine cells are local
endocrine cells that secret gastrointestinal hormones, such as
somatostatin, cholecystokinin and glucagon; and (3) goblet
cells which have the sole function to secret mucus, protecting
the intestinal barrier from mechanical damage. The crypts
contain two types of cells: (1) Paneth cells are also terminally
differentiated, and secrete anti-microbial peptides in response
to pathogens; and (2) undifferentiated stem cells which reside
within crypts, and undergo self-renewal, proliferation, and
eventually differentiate into all the above-mentioned termi-
nally differentiated cells [1–3]. The structural and functional
integrity of the small intestine is largely dependent upon a
continuous and well-organized flow of fully differentiated
cell lineages migrating from the crypts. However, the
molecular mechanisms by which the individual cell lineages
are derived from the crypts await full characterization.
A number of cellular signaling pathways have been
suggested to be involved in small intestinal cell proliferation
and differentiation, among which the Delta-Notch pathway
and Wnt/beta-catenin/T cell factor 4 (TCF4) pathway have
drawn most attention [3–5]. Activation of the highly con-
served Delta-Notch signaling pathway is usually considered
to maintain the proliferative state of the intestinal progenitor
cells, and lead to columnar cell lineages rather than secre-
tory cells [6–10]; The Wnt/beta-catenin/TCF4 signaling
pathway instead plays a key role in maintaining progenitor
cells in the proliferative state and making them select
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towards secretory cells [11–15]. Decreased Wnt signaling
decreases the size of crypts [12], and aberrant upregulation
of the Wnt signaling is associated with local tumorigenesis
[16, 17]. However, the molecular determination of indi-
vidual terminally differentiated cell lineages does not rely
solely on either Notch or Wnt signaling but on the coordi-
nate interaction of the two [3, 18, 19].
Wnt signal activates three independent pathways, the
canonical Wnt/beta-catenin cascade, the noncanonical
planar cell polarity pathway, and the Wnt/Ca2? pathway.
The intestinal crypts express members of the canonical
Wnt/beta-catenin pathway [20]. The locally expressed Wnt
molecule binds to the surface receptor frizzled, and stabi-
lizes cytosolic transcriptional factor beta-catenin from
degradation. Subsequently, downstream functional out-
comes are elicited by the translocation of beta-catenin to
the nucleus, where it forms a nuclear binding complex with
TCF4, a member of T-cell factors and specifically
expressed in the small intestine, and the complex subse-
quently regulates transcription of a variety of genes.
The end effect of Wnt signaling is a result of gene
transactivation by the nuclear beta-catenin/TCF4 complex.
To date, genes in the intestine that have been found to be
downstream targets of beta-catenin/TCF4 transactivation
include PKC [21], p16(INK4a) [22], S100A4 [23], Rad6B
[24], c-myc [25], cyclin D1 [26], MMP-7 [27], PPARd
[28], and cohesion SMC3 [29], which are mostly involved
in tumorigenesis. The downstream targets of beta-catenin/
TCF4 binding complex responsible for normal intestinal
homeostasis, however, remain an open question.
microRNAs (miRNAs), typically*22 nucleotides (nt) in
size, are a large family of non-coding RNA molecules that
can repress gene expression post-transcriptionally [30–32].
miRNAs regulate genes in a variety of biological processes,
and have been shown to mediate differentiation of specific
cell types, including B-cells and T-cells [33], cardiac and
somatic muscle progenitors [34], osteoblasts [35], adipo-
cytes [36], neurons [37], and embryonic stem cells [38]. In
particular, miR-194 was recently found to interact with the
transcription factor HNF1-alpha during intestinal epithelial
cell differentiation in a Caco-2 cell model [39].
The objective of this study was to determine whether
specific miRNA(s) could be the downstream target of the




IEC-6 cells were seeded onto sterile glass coverslips at 85%
confluency per 24-well culture plates the day prior to each
experiment, and cells were fixed with 4% paraformaldehyde
in DEPC-treated 19 phosphate-buffered saline (PBS) for
30 min and permeabilized with 0.2% Triton X-100 in
DEPC-treated 19 PBS for 5 min. Endogenous peroxidase
activity was blocked in 1% H2O2 for 3 min. Non-specific
hybridization was blocked with hybridization buffer (50%
formamide, 0.5% SDS, 59 SSPE, 59 Denhardt’s solution,
and 20 lg/ml sheared, denatured, salmon sperm DNA) at
42C for 2 h. miR-30e LNA probe 50-labeled with Digox-
igenin (Exiqon) was diluted to 2.5 nM in hybridization
buffer and incubated with the cells for 16 h at 42C.
Stringency wash was performed with 29 SSC, 0.1% SDS at
42C three times for 10 min each, and 0.19 SSC, 0.1% SDS
at 65C three times for 10 min each. The cells were incu-
bated with 5% BSA in TNT buffer (0.1 M Tris–HCl, pH
7.5, 0.15 M NaCl, and 0.05% Tween 20) for 30 min, and
incubated with anti-DIG-HRP (Roche) for 30 min. Subse-
quently, fluorescence was detected with the TSA Cy5
system (Perkin Elmer). Non-specific staining was deter-
mined by using scrambled-miR detection probe (Exiqon),
RNase A (Invitrogen) treatment of the cells before hybrid-
ization, incubating the sections without probe, and
incubating with TSA Cy5 system alone after hybridization.
Nuclei were stained with 0.3 lg/ml DAPI (Invitrogen) in
19 PBS for 5 min. Coverslips were mounted in ProLong
Gold (Invitrogen) and sealed with nail polish. Fluorescent
signals were captured under the Olympus FV1000 confocal
microscope at the Microscopy and Imaging facility of the
section of Molecular and Cell Biology at UCDavis.
Bioinformatic sequence analysis
The mature miR-30e sequences of human, mouse, and rat
were retrieved from the miRBase Sequence Database
(http://microrna.sanger.ac.uk/sequences/) and the sequen-
ces were found to be identical and conserved between the
three species.
The sequence of the miR-30e promoter was retrieved
from the Table Browser (http://genome.ucsc.edu/cgi-bin/
hgTables) at UCSC (University of California, Santa Cruz)
Genome Bioinformatics (http://genome.ucsc.edu). The
BAC containing the miR-30e promoter region was identi-
fied from the Genome Browser (http://genome.ucsc.edu/
cgi-bin/hgGateway) using human Mar. 2006 assembly.
Transcriptional factor binding sites were predicted by
the Transcription Element Search System (http://www.
cbil.upenn.edu/cgi-bin/tess/tess) and the TFSEARCH sys-
tem (http://www.cbrc.jp/research/db/TFSEARCH.html).
Plasmid vector construction
A 2,000-bp fragment of the miR-30e promoter region
was PCR amplified from a BAC CTD-3060E5 (Open
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Biosystems). The primer sequences used for PCR ampli-
fication were promoter forward, 50CGCAGATCTCTTAA
CTATACATAATATGTTGGG30, reverse, 50CGCAAGCT
TGTAGCAAAGACTGCCCAGAAAG30. The PCR prod-
uct was cloned into pBluescript SK(?) vector (Stratagene).
The enhancer region of the pGL3-control luciferase
reporter vector (Promega) was removed via BglII and
HindIII sites. Subsequently, the promoter sequence was
excised from pBluescript SK (?) and cloned into pGL3-
control luciferase reporter vector without the enhancer
region; the resulting vector was named miR30epromoter-
pGL3 vector.
The pBluescriptR-TCF4 vector containing TCF4 full-
length cDNA was from Open Biosystems. The TCF4
cDNA sequences containing the coding sequence (CDS)
and the PCMV-SPORT6 vector backbone were retrieved
from pBluescriptR-TCF4 vector and PCMV-SPORT6-
beta-catenin vector (Open Biosystems) by ApaI and EcoRI,
respectively. Subsequently, the TCF4 cDNA CDS was
cloned into the PCMV-SPORT6 vector backbone.
Site-directed mutagenesis was performed to silence the
putative TCF4 binding site within the miR-30e promoter
region. The mutation was introduced by PCR using the
following primers: 30emut1 forward, 50-GTAAAAATCTT
TTAATTTTATTATTCAAAGAAAGGAAG-30, reverse
50-CTTCCTTTCTTTGAATAATAAAATTAAAAGATTT
TTAC-30; 30emut2 forward, 50-GTATCTCTTTCTTGC
GCAACGATGGTTGCCCACCAG-30, reverse 50-CTGGT
GGGCAACCATCGTTGCGCAAGAAAGAGATAC-30
(mutation underlined). Mutagenesis was carried out using
the Quickchange site-directed mutagenesis kit from Strat-
agene. The mutated vector was named mut-pGL3-miR30e.
Fidelity and orientation of the cloning were confirmed
by DNA sequencing (UCDavis, Division of Biological
Sciences Automated DNA Sequencing Facility).
Cell culture and transfections
HEK293 cells (ATCC# CRL-1573) were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) with 1.5 g/l
sodium bicarbonate, 10% FBS (Sigma), 100 U/ml peni-
cillin, 100 mg/ml streptomycin (Sigma), and incubated at
37C, 5% CO2.
IEC-6 cells (ATCC# CRL-1592) were maintained in
DMEM with 1.5 g/l sodium bicarbonate, 10% FBS
(Sigma), 100 U/ml penicillin, and 100 mg/ml streptomycin
(Sigma), 0.1 U/ml bovine insulin (Sigma) and incubated at
37C, 5% CO2. Cells were passaged when approximately
90% confluent at 1:4, and cell stocks were not used after 7
passages upon arrival from ATCC.
All transfections were carried out with Lipofectamine
2000 (Invitrogen) according to the manufacturer’s
instructions.
For luciferase assays, HEK293 cells were seeded at 70%
confluency per 96-well plates the day prior to transfection
with 3.5 lg/ml luciferase expression construct, pCMV-
SPORT6-beta-catenin expression vector (Open Biosys-
tems), and pCMV-SPORT6-TCF4 expression vector. Mock
transfected cells were transfected with luciferase expression
construct alone. PGL4.73[hRluc/SV40] vector (Promega)
served as an internal control for transfection efficiency.
Luciferase activity was measured 24 h after transfection
using the Dual-Glo Luciferase Assay System (Promega).
For dexamethasone treatment, IEC-6 cells were seeded
at 60% confluency per 6-well plates the day prior to
treatment with 100 nM cell culture grade dexamethasone
(Sigma), the control group was treated with the vehicle
ethanol alone, and the cells were collected 48 h after
treatment for real-time Quantitative-Polymerase Chain
Reaction (Q-PCR) and immunoblotting analysis.
For beta-catenin siRNA and TCF4 siRNA, IEC-6 cells
were seeded at 70% confluency per 6-well plates the day
prior to transfection with 75 nM beta-catenin siRNA (siRNA
ID: 190086), or 100 nM TCF4 siRNA (siRNA ID: 195500).
Mock transfected cells were transfected with transfection
reagent alone, and the cells were collected 48 h after trans-
fection for real-time Q-PCR and immunoblotting analysis.
Immunoblotting analysis
IEC-6 cells were homogenized in Tris buffer [50 mM
TrisHCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1%
SDS, 1 mM EDTA (ethylenediamine tetraacetic acid), and
0.5% sodium deoxycholate] containing 19 complete
EDTA-free protease inhibitor (Roche), and 40 lg proteins
were electrophoresed through 10% polyacrylamide gel,
transferred onto nitrocellulose membrane at 350 mA for
60 min, and blocked overnight in 19 PBS/0.1% Tween-20
(PBST) with 5% non-fat milk at 4C.
Antibodies against beta-catenin and TCF4 were purchased
from Santa Cruz Biotechnology. The blots were incubated
with anti-rat beta-catenin (1:500 in PBST with 5% non-fat
milk) and anti-rat-TCF4 (1:200 in PBST with 5% non-fat
milk) at room temperature for 1 h, washed for 15 min with
PBST, and incubated with rabbit anti-mouse IgG horseradish
peroxidase linked secondary antibody (DakoCytomation)
(1:2,000 in PBST with 5% non-fat milk). Bands were detected
using Super Signal Femto chemiluminescent reagent (Pierce)
and quantified using the Chemi-doc gel quantification system
(Bio-Rad). All data were normalized to beta-actin.
Real-time Q-PCR
Total RNA from IEC-6 cells were isolated using mirVana
microRNA isolation kit (Ambion) and diluted to 2 lg/ll in
DEPC-treated water (Ambion).
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For miR-30e assay, cDNA was generated from 2 lg
RNA using TaqMan MicroRNA Reverse Transcription
Kit (Applied Biosystems) according to the manufacturer’s
protocol. The miR-30e gene specific stem-loop RT primer
for reverse transcription was designed according to miR-
NAs sequences listed in the Sanger miRBase (http://
microrna.sanger.ac.uk/sequences/), and the reaction was
performed at 16C for 30 min, followed by 42C for
30 min and 85C for 5 min. Relative expression of miR-
30e and U87 (internal standard) were determined by real-
time Q-PCR using a FAM detection system (Applied
Biosystems). The reaction was performed in a 15-ll reac-
tion mixture using the ABI 7900 HT real-time
thermocycler (Applied Biosystems) with the following
protocol: 50C for 2 min, 95C for 10 min, 40 cycles of
95C for 15 s, 60C for 1 min.
Each sample was analyzed in triplicate and normalized
to U87 for miR-30e, using the following equation:
DCtGENE = CtGENE - CtU87. The fold change, relative to
the control group which was used as the internal control,
was calculated using the following equation: 2(DDCtGENE)
where DDCtGENE = DCtGENE of U87 - DCtGENE of
each well.
Electrophoretic mobility shift assay (EMSA)
Nuclear proteins from IEC-6 cells treated with dexameth-
asone were extracted by NE-PER nuclear extraction kit
(Pierce). Biotin labeled probes were synthesized at Bio-
neer. The following oligos and their anti-sense oligos were
synthesized and annealed: 50CTGCTTGCTTTGTTATAT
AAAAC30, corresponding to the -272/-250 bp region of
miR-30e promoter; 50CCGCTCTTCTTTGTTACAGAGA
AATG30, corresponding to the -1,239/-1,214 region of
miR-30e promoter. EMSA reactions (20 ll) were assem-
bled using LightShift Chemiluminescent EMSA Kit
(Pierce), and the reaction contained 2 nM of biotin-labeled
ds oligonucleotide, 19 binding buffer, 1 ll 1 lg/ll Poly
(dI•dC), 1 ll 50% glycerol, 1 ll 1% NP-40, 1 ll 1 M KCl,
1 ll 100 mM MgCl2, and/or 3 ll NE-PER nuclear extracts,
4 pmol unlabeled probe. Mixtures of protein and DNA
were incubated for 30 min at room temperature. Following
addition of 5 ll loading buffer, bound and free DNA were
resolved by fractionation on 5% native polyacrylamide
TBE gel (Bio-Rad) in 0.59 TBE. Gels were pre-run for 1 h
at 100 V at room temperature using the Miniprotean II
system (Bio-Rad), and run with samples under the same
conditions for 45 min. The DNA/protein complex was
transferred onto Biodyne B Nylon Membrane (Pierce) at
400 mA for 35 min. The transferred DNA was cross-linked
to the membrane at 120 mJ/cm2 for 60 s using a GS
Gene Linker (Bio-Rad) equipped with a 254 nm bulb.
The biotin-labeled DNA was detected by means of the
Chemiluminescent Nucleic Acid Detection Module
(Pierce).
Chromatin immunoprecipitation (ChIP)
IEC-6 cells in 6-well culture plates were treated with
dexamethasone, and fixed with 1% formaldehyde, washed
with ice-cold 19 PBS, harvested, lysed and sonicated. The
soluble chromatin containing supernatant was then sub-
jected to immunoprecipitation using anti-beta-catenin and
anti-TCF4 antibodies (Santa Cruz Biotechnology) at 4C
overnight, followed by adding protein A agarose and
salmon sperm DNA. Unrelated immunoglobulin G (IgG)
was used as a negative control for immunoprecipitation.
Precipitated DNA was recovered via phenol/chloroform
extraction and amplified by RT-PCR for 40 cycles using
specific primer sets for the indicated specific promoter
regions of miR-30e. The PCR primers for ChIP assays are:
region1 (-1348/-1103) forward, 50CAGCTGTAGACT
TGCCCGTAG30, reverse 50CTGCAATCCCTTCACAGC
TC30; region2 (-386/-149) forward, 50AATAGACCTCT
GTCCTTTAGAGC30, reverse, CTCTGACTGGTTATTA
ATACAGGC30; region3 (-1535/-1328) forward, 50CTG
CTAATTGAGATTACTAGGTTTG30, reverse, CTACGG
GCAAGTCTACAGCTG30; region4 (-1991/-1787) for-
ward, 50CTTAACTATACATAATATGTT30, reverse 50CA
TAGCTTGTGAGAATTCTGATAT30. The DNA sequence
corresponding to the ?927/?1,168 region served as nega-
tive control: control forward, 50GAGGCCACTGCTAAA
GTTGA30, reverse, 50TTTAGTGGGGCAGAAGTCAG30.
Data analysis
All data were analyzed by Prism (Prism GraphPad Soft-
ware). The effect of beta-catenin/TCF4 overexpression on
the luciferase activity in HEK293 cells and beta-catenin/
TCF4 siRNAs on miR-30e expression in IEC-6 cells were
tested by Student’s t test. Data are shown as means ± SEM
of two replicates and are representative of three indepen-
dent experiments. Differences were considered significant
when P \ 0.05.
Results
miR-30e is present in the IEC-6 crypt cell line
To investigate if miR-30e is present in small intestinal
crypt cells, we used confocal microscopy and determined
that, in IEC-6 cells, there is an intense staining at the peri-
nuclear region for miR-30e, with low levels of diffusion in
the cytosol and nucleus (Fig. 1a). No staining was observed
by incubating with scrambled miRNA detection probe,
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with RNase A treatment before hybridization, or with TSA
Cy5 system alone.
The miR-30e promoter region contains clustered
binding sites for beta-catenin/TCF4
To characterize the transcriptional factor binding sites
within the miR-30e promoter, miRBase Sequences Data-
base was used to identify the mature miR-30e sequences
from human, mouse, and rat, and they were found to share
the identical sequence of 50UGUAAACAUCCUUGAC
UGGAAG30. Furthermore, the promoter sequences were
examined for the presence of putative transcriptional
factor binding sites for beta-catenin/TCF4 in TESS and
TFSEARCH databases. Within a 2,000-bp promoter
region, all three sequences contained two canonical beta-
catenin/TCF4 binding sites (50CTTTGTT30) (black arrow-
head in Fig. 2); moreover, the mouse and rat promoter
harbored one additional beta-catenin/TCF4 binding site,
50AACAAAG30 (empty arrowhead in Fig. 2). The human,
mouse, and rat promoter further contained two, three, and
four TCF4 binding sequences (50TTTTGTT30) (sketched
arrowhead in Fig. 2).
Overexpression of beta-catenin and TCF4 enhances
miR-30e promoter activity
To assess the potential role of beta-catenin and TCF4 in
regulation of the miR-30e gene promoter, we determined if
the promoter activity was affected by the level of intra-
cellular beta-catenin and TCF4 using a luciferase reporter
assay. A dose-dependent increase in the luciferase activity
was observed with increasing concentrations of beta-
catenin expression vector ranging from 0.15 to 1.5 lg/ml
(P \ 0.05) (Fig. 3a), indicating increased luciferase gene
transactivation through the promoter. Beta-catenin at con-
centrations higher than 2 lg/ml decreased cell survival
when examined 24 h post-transfection (data not shown).
Co-transfection of 1.2 lg/ml TCF4 expression vector fur-
ther potentiated the enhancing effect of beta-catenin
(P \ 0.01) (Fig. 3b), in line with the fact that TCF4
facilitates translocalization of beta-catenin to the nucleus
and binding to target genes. When the TTTTGTT sites
were mutated, TCF4 overexpression did not result in fur-
ther enhancement of the luciferase activity, as indicated by
similar luciferase activity shown in Fig. 3c and d. This
provides functional evidence that TCF4 directly regulates
beta-catenin activity through TTTTGTT sites within the
miR30e promoter region.
miR-30e is associated with beta-catenin during
dexamethasone induced cell differentiation
To determine the functional relationship between miR-30e
and beta-catenin, IEC-6 cells were treated with 100 nM
dexamethasone for 48 h to induce cell differentiation. In
differentiated cells, miR-30e expression was upregulated
compared to undifferentiated cells (1.00 ± 0.20 vs
2.58 ± 0.26; P \ 0.01), while 75 nM beta-catenin siRNA
knocked-down beta-catenin protein expression by 50%,
and miR-30e expression increased to 1.3-fold compared
to undifferentiated cells (1.00 ± 0.20 vs 1.29 ± 0.32;
P = 0.49), which is significantly different from cells
treated with dexamethasone alone (1.29 ± 0.32 vs 2.58 ±
0.26; P \ 0.05) (Fig. 4a); In addition, 100 nM TCF4 siR-
NA knocked-down TCF4 protein expression by 50%, and
miR-30e expression increased 0.4-fold compared to undif-
ferentiated cells (1.00 ± 0.04 vs 1.42 ± 0.16; P = 0.1148),
Fig. 1 Subcellular localization
of miR-30e in IEC-6 cells.
miR-30e distribution in IEC-6
cells was examined by confocal
microscopy. Paraformaldehyde-
fixed cells were probed with
LNA DIG-miR-30e probe.
Reactivities were visualized by
TSA Cy5 system (red a), and
nuclei were stained with DAPI
nucleic acid dye (blue b). c The
peri-nuclear localization of
miR-30e. Magnification of 960
under oil. Scale bar 10 lm
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which is also significantly different from cells treated
with dexamethasone alone (1.42 ± 0.16 vs 1.86 ± 0.17,
P \ 0.05) (Fig. 4b).
Putative binding sequences within the miR-30e
promoter actively bind beta-catenin/TCF4
The binding properties of the beta-catenin were confirmed
by performing EMSA and supershift assay. DNA probes of
23–26 bp long, containing the putative beta-catenin/TCF4
core binding sequences (-265/-259, -1,231/-1,225) and
their flanking region at both sides within the human miR-
30e promoter, were tested. Incubation of the biotin-labeled
probe -1,239/-1,214 with IEC-6 cell nuclear extracts
caused a major retarded band as a result of the binding
between the labeled probe and the beta-catenin/TCF4
transactivation complex (Fig. 5a, lane 1). An excessive
amount of unlabeled probe prevented the labeled probe
from binding with the transactivation complex, as indicated
by no retarded band (Fig. 5a, lane 2). Incubation with beta-
Fig. 2 Comparative sequence
analysis of miR-30e gene
promoter from human, mouse,
and rat. The promoter sequences
were retrieved from miRBase
Sequences Database, and the
analysis was performed at TESS
and TFSEARCH. The binding
domains for two types of beta-
catenin/TCF4 complex are
shown with black and empty
arrowheads, and for TCF4 with
hatched arrowheads
Fig. 3 Effect of beta-catenin/TCF4 overexpression on the miR-30e
gene promoter activity. IEC-6 cells were co-transfected with 3.5 lg/ml
luciferase expression vector containing wild-type and mutated miR-
30e promoter and increasing concentrations of pCMV-SPORT6-beta-
catenin expression vector without (a,c) or with (b,d) 1.2 lg/ml
pCMV-SPORT6-TCF4 expression vector. Luciferase activity was
corrected for transfection efficiency based on pGL4.73[hRluc/SV40]
vector transfection. Beta-catenin overexpression dose-dependently
increased the luciferase activity (P \ 0.05) (a) and overexpresison of
TCF4 further enhanced the effect from beta-catenin (P \ 0.05) (b).
When the TTTTGTT sites were mutated, overexpression of TCF4 did
not further enhance the effects of beta-catenin (c,d). Values are
means ± SEM run in triplicates; asterisks indicate significant differ-
ences between treatment and control groups
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catenin antibody, but not an irrelevant antibody (alkaline
phosphatase), further shifted the band indicating the pres-
ence of beta-catenin in the binding complex (Fig. 5a, lanes
3 and 4). Identical data were obtained for the other probe
corresponding to -272/-250 bp within the human
miR-30e promoter (data not shown).
The binding properties of beta-catenin/TCF4 to the miR-
30e promoter were also observed by ChIP assay. Antibody
against beta-catenin/TCF4 was used to immunoprecipitate
the protein–chromatin complex. As depicted in Fig. 5b,
specific binding of beta-catenin/TCF4 to the miR-30e
promoter region (-1,348/-1,103, Fig. 5b region 1 panel;
-386/-149, Fig. 5b region 2 panel), and specific binding
of TCF4 to miR-30e promoter region (-1,535/-1,328,
Fig. 5b region 3 panel; -1,991/-1,787, Fig. 5b region 4
panel), but not to a negative control region (?927/?1,168,
Fig. 5b bottom panel) was observed.
Fig. 4 Effects of beta-catenin and TCF4 knock-down on miR-30e
expression during dexamethasone induced cell differentiation. IEC-6
cells were treated with 100 nM dexamethasone for 48 h with or
without 75 nM beta-catenin siRNA, 100 nM TCF4 siRNA. Total
RNA was extracted and analyzed for miR-30 expression by real-time
Q-PCR. miR-30e significantly increased upon dexamethasone treat-
ment (P \ 0.05), beta-catenin siRNA and TCF4 siRNA both blocked
the upregulation. Values are means ± SEM run in triplicates, asterisk
indicates significant differences between dexamethasone treatment
alone and control group, letters indicate significant differences
between dexamethasone treatments without (a) and with (b) siRNA
treatment
Fig. 5 Identification of beta-catenin/TCF4 binding sites within the
2,000-bp miR-30e promoter region. a 3 ll of IEC-6 cell NE-PER
nuclear extracts were incubated with 2 nM biotin-labeled DNA probe
corresponding to the human miR-30e promoter sequence -1,239/-
1,214 bp (lane 1). For binding competetion, 50-fold excess of
unlabeled DNA probe was included in the reaction (lane 2). For
supershift assay, 0.5 lg beta-catenin antibody (lane 3) or an irrelevant
antibody (antibody for alkaline phosphatase, lane 4) were included.
Supershift was also observed for probe corresponding to -272/-
250 bp region of the miR-30e promoter (data not shown). b IEC-6
cells treated with dexamethasone, the precipitated DNA, along with
the DNA isolated before immunoprecipitation (Input), were analyzed
by PCR amplication with specific primers corresponding to the
region1 (-1,348/-1,103), region2 (-386/-149), region3 (-1,535 to
-1,328), region4 (-1,991 to -1,787) and negative control (?927/
?1,168)
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Discussion
miRNAs are non-protein coding RNA molecules, classified
as small regulatory RNAs. Although miRNAs have been
suggested to mediate the differentiation of neurogenesis,
myogenesis, and lymphogenesis, there have been very few
reports demonstrating a role for miRNAs during small
intestinal cell differentiation. However, a recent report of
Hino et al. [39] found miR-194 to be the downstream
regulator of transcriptional factor HNF-1a, which has been
suggested to be required in the lineage selection toward
enteroendocrine cells [40] and enterocytes [41]. The roles
of other miRNAs in the classical signaling pathways of
small intestinal stem cell differentiation remain to be
determined. During intestinal cell differentiation, a large
number of kinases and phosphatases are activated/inacti-
vated, which all require regulatory molecules. As one of
the characteristics of the miRNA pathway is their multi-
target mechanism in coordinately fine-tuning biological
networks, and the Wnt/beta-catenin/TCF4 signaling has the
potential of transactivating different downstream genes by
DNA binding, we hypothesized that, in addition to target-
ing protein-coding genes, beta-catenin/TCF4 targets
miRNA during intestinal cell differentiation.
We initiated this project by finding candidate miRNAs
in the miRBase sequence database by using Transcriptional
Factor Prediction tools. These analyses pinpointed miR-
NAs of interest and, as a result of these bioinformatics
analyses, miR-30e was identified to have high frequency
clustered beta-catenin/TCF4 binding sites at the gene pro-
moter. So far, there are limited reports specifically
addressing the function of miR-30e. Wu et al. [54] found
that miR-30e regulates Ubc9 expression in cancer cells,
and ectopic expression of miR-30e was found to suppress
cell proliferation. Our results support miR-30e as a medi-
ator in the cell differentiation process, which suggests a
role for miR-30 in the maintenance of cellular
development.
Furthermore, the localization of two beta-catenin/TCF4
binding sites is conserved across the three species; one is a
canonical beta-catenin/TCF4 binding site (50CTTTGTT30),
located at -265/-259 and -1,231/-1,225 upstream of the
transcription start site; and the other is a TCF4 binding site
(50TTTTGTT30), located at -1,947/-1,941 and -1,412/
-1,406 from the transcription start site. Remarkably, in the
luciferase reporter assay, with pGL3 vector containing both
CTTTGTT and TTTTGTT binding sites, TCF4 co-trans-
fection further enhanced the beta-catenin up-regulated
luciferase activities by 1.62-, 1.38-, 1.27-, 1.12-, and 1.15-
fold at beta-catenin concentrations 0.15, 0.3, 0.6, 1.2, and
1.5 lg/ml, respectively (Fig. 3b); mutation of the two
TTTTGTT sites abolished the ability of the TCF4 expres-
sion vector to further enhance the up-regulation of
luciferase activity (Fig. 3c, d), supporting the argument for
TTTTGTT being one of the TCF4 binding sites which
directly regulates beta-catenin activity.
Interestingly, putative binding sites for some other
transcriptional factors involved in intestinal cell differen-
tiation were also identified within the miR-30e promoter
region (TESS/TFSEARCH). miR-30e promoter of human,
mouse, and rat all contain two CDX-1 binding sites. CDX-1
is an intestine-specific transcriptional factor expressed in
the lower part of the crypts, and overexpression of CDX-1
by stable transfection in IEC-6 cells induced enterocyte
differentiation; morphology of the top layer also showed
characteristics of epithelial cells after transfection [42, 43].
The miR-30e promoter also contained more than 15 bind-
ing sites for nuclear factor AP-1 (human 19, mouse 18, and
rat 19), and AP-1 binding activity was increased in Caco-2
cells at post-confluency during spontaneous differentiation
into the enterocyte phenotype [44]. Lastly, there is a
presence of conserved HES1 binding sites (human 5,
mouse 4, rat 2). HES1 is a transcriptional gene repressor:
HES1 knock-out mice have an increased number of lyso-
zyme-positive and cryptdin-4-positive cells, indicating
their inhibitory role in Paneth cell differentiation [45]. The
presence of binding domains for other differentiation-
related transcriptional factors further supports the concept
that miR-30e targets intestinal cell differentiation.
IEC-6 cells were originally established from intestinal
crypt cells, and bear the characteristics of undifferentiated
intestinal cells morphologically and immunologically [46].
Cortisol and thyroid hormones are essential in the matura-
tion of fetal organs, tissues and molecular signaling, and
glucocorticoids have been well characterized to stimulate
intestinal maturation by influencing morphological, cyto-
logical, and functional differentiation [47, 48]. In our study,
dexamethasone was used to elicit differentiation events in
IEC-6 cells, and the treatment was able to upregulate gene
markers for absorptive enterocytes (ALP) [49, 50], Paneth
cells (Lyzs, Pglyrp1 and spink4) [15, 51], goblet cells
(trefoil F3), and enteroendocrine cells (CCK and Collagen
IV) [52, 53] (data not shown). Normally, beta-catenin in the
cells is constantly expressed and degraded, and in the Wnt
signaling pathway, the presence of extracellular Wnt signal
stabilizes beta-catenin, which in turn associates with TCF
family transcription factors, resulting in beta-catenin/TCF
complex formation and subsequent translocation to the
nucleus. There is a balanced expression level of beta-cate-
nin in the cytoplasm, and it is the translocation to the
nucleus that matters to transduce the Wnt signal. In the
present study, dexamethasone did not significantly affect
total beta-catenin or TCF4 protein, but as can be seen from
the EMSA and ChIP data, beta-catenin and TCF4 were both
found to be translocated to the nucleus, where they cause
the change in miR-30e expression.
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According to the cellular model suggested by Crosnier
et al. [3], the Wnt/beta-catenin/TCF4 pathway and Delta-
Notch pathway jointly maintain and commit the intestinal
progenitor cells: (Wnt?, Notch-) cells become secretory
cell types; (Wnt?, Notch?) cells continue to divide without
differentiation; thereafter, cells which lose Wnt activation
differentiate into absorptive cells if Notch remains activated
in them and differentiate into secretory cells if Notch sig-
naling is also inactivated. From the observations of this
study, we suggest that dexamethasone treatment elicited
dynamic responses in IEC-6 cells in regard to the control of
Wnt and Notch signaling, and as a result, the undifferenti-
ated crypt cells were able to give rise to terminally
differentiated intestinal cell types, further showing that the
IEC-6 cell line is a good model to study Wnt/Notch sig-
naling during intestinal cell differentiation. In the present
study, the in situ hybridization (Fig. 2) experiment con-
firmed the cytolocalization of miR-30e in IEC-6 cells, and
down-regulation of miR-30e after beta-catenin or TCF4
knock-down during dexamethasone-induced cell differen-
tiation (off-target effect was excluded by using siRNA
targeting a different region of the gene). Furthermore, in
luciferase reporter assays, not only did the beta-catenin
transactivation cause an increase in miR-30e promoter
activity but also co-expression of TCF4 enhanced the effect
of beta-catenin on miR-30e promoter activity, mimicking in
vivo events, where TCF4 enters the nucleus in response to
Wnt signal and forms stimulatory complexes with beta-
catenin. These observations all directly argue the presence
of a dexamethasone–beta-catenin/TCF4-miR-30e axis.
In conclusion, in intestinal crypt cells, beta-catenin/
TCF4, an essential component in Wnt signalling, directly
binds to miR-30e, and this binding is directly involved in
dexamethasone-induced cell differentiation, suggesting
that miR-30e is an immediate downstream target for the
beta-catenin/TCF4 transactivation pathway during intesti-
nal cell differentiation.
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